Immutep Limited
PRRUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $420 | $330 | $294 | $275 |
| - Cash | $67 | $162 | $123 | $80 |
| + Debt | $2 | $2 | $1 | $2 |
| Enterprise Value | $354 | $170 | $172 | $197 |
| Revenue | $5 | $4 | $4 | $0 |
| % Growth | 31.3% | 9.6% | 1,957.7% | – |
| Gross Profit | -$56 | -$38 | $1 | -$27 |
| % Margin | -1,117.6% | -981.4% | 41.2% | -15,629.1% |
| EBITDA | -$63 | -$45 | -$40 | -$32 |
| % Margin | -1,246.6% | -1,159.4% | -1,128.8% | -18,708.9% |
| Net Income | -$61 | -$43 | -$40 | -$32 |
| % Margin | -1,218% | -1,111.9% | -1,138% | -18,906.5% |
| EPS Diluted | -0.042 | -0.036 | -0.044 | -0.037 |
| % Growth | -18.5% | 19.6% | -18.4% | – |
| Operating Cash Flow | -$62 | -$35 | -$35 | -$30 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$62 | -$36 | -$35 | -$30 |